PKM2在牙源性角化囊肿中的研究进展

doi:10.13701/j.cnki.kqyxyj.2024.11.003

摘要/Abstract

摘要： 牙源性角化囊肿(odontogenic keratocyst,OKC)是一种具有潜在侵袭性、易复发和多发的发育性囊肿,能量代谢途径主要以糖酵解为主。丙酮酸激酶的M2亚型(pyruvate kinase M2,PKM2)是糖酵解关键调动因子,在调控肿瘤代谢微环境中发挥重要作用。为了降低OKC术后复发率,同时合理保存和重建患者口腔结构和功能,OKC相关基础和临床研究不断深入,特别是中医药对口腔肿瘤免疫微环境稳态作用机理值得深入研究。本文针对PKM2在OKC中的研究进展作一综述,以期为OKC的临床治疗提供参考及新思路。

关键词: 牙源性角化囊肿, 丙酮酸激酶的M2亚型, 糖酵解, 肿瘤, 中医药, 微环境

Abstract: The odontogenic keratocyst (OKC) is a developmental cyst that has high potential for invasiveness, easy recurrence, and multiple occurrences. Its energy metabolism pathway is mainly glycolysis. Pyruvate kinase M2 (PKM2) is a key driving factor of glycolysis and plays an important role in regulating the tumor metabolic microenvironment. The traditional Chinese medicine (TCM) has a long history of treating tumors with its unique theory of "steady-state" effect on the tumor immune microenvironment. This review will delve into the regulation of PKM2 in respect of odontogenic keratocysts, aiming to provide new ideas for the clinical treatment of OKC with traditional Chinese medicine.

Key words: odontogenic keratocyst, pyruvate kinase M2, glycolysis, tumor, traditional Chinese medicine, microenvironment

王皓珺, 查光玉. PKM2在牙源性角化囊肿中的研究进展[J]. 口腔医学研究, 2024, 40(11): 956-959.

WANG Haojun, ZHA Guangyu. Research Progress of PKM2 in Odontogenic Keratocysts[J]. Journal of Oral Science Research, 2024, 40(11): 956-959.

参考文献

[1] 刘冰,何悦,彭歆,等.牙源性角化囊肿诊疗中国专家共识[J].中国口腔颌面外科杂志,2022,20(3):209-218.
[2] Loreto C, Polizzi A, Filetti V, et al. Expression of matrix metalloproteinases 7 and 9, desmin, alpha-smooth muscle actin and caldesmon, in odontogenic keratocyst associated with NBCCS, recurrent and sporadic keratocysts [J]. Biomolecules, 2022, 12(6):775.
[3] 王润兮,杨舒涵,房立源,等. 中医药“以平为期”调整肿瘤免疫微环境稳态[J].肿瘤防治研究,2023,50 (11): 1114-1120.
[4] Qi H, Zhang X, Liu H, et al. Shikonin induced apoptosis mediated by endoplasmic reticulum stress in colorectal cancer cells [J]. J Cancer, 2022, 13(1):243-252.
[5] Zou Y, Wang R, Zhao J, et al. Increased M2 isoform of pyruvate kinase in fibroblasts contributes to the growth, aggressiveness, and osteoclastogenesis of odontogenic keratocysts [J]. Am J Pathol, 2021, 191(5):857-871.
[6] Man QW. HIF-1α signaling pathway is related with glycolysis in odontogenic keratocysts at single-cell level [J]. Oral Dis, 2024, 30(5):3501-3503.
[7] Jaworska M, Szczudło J, Pietrzyk A, et al. The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells [J]. Pharmacol Rep, 2023, 75(4):876-890.
[8] 王娜,周亚丽,宋飞雪,等.肿瘤糖酵解与肿瘤免疫微环境关系的研究进展[J].癌症进展,2022, 20(12): 1194-1197.
[9] Zhang Z, Deng X, Liu Y, et al. PKM2, function and expression and regulation [J]. Cell Biosci, 2019, 9:52.
[10] Zhu S, Guo Y, Zhang X, et al. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics [J]. Cancer Lett, 2021, 503:240-248.
[11] Niu N, Ye J, Hu Z, et al. Regulative roles of metabolic plasticity caused by mitochondrial oxidative phosphorylation and glycolysis on the initiation and progression of tumorigenesis [J]. Int J Mol Sci, 2023, 24(8):7076.
[12] Wang K, Zhang C, Zhou H, et al. Detection of glucose transporter 1 in living cells for assessment of tumor development and therapy using an electrochemical biosensor [J]. Biosens Bioelectron, 2024, 244:115820.
[13] Yang X, Chen W, Zhao X, et al. Pyruvate kinase M2 modulates the glycolysis of chondrocyte and extracellular matrix in osteoarthritis [J]. DNA Cell Biol, 2018, 37(3):271-277.
[14] Pragallapati S, Manyam R. Glucose transporter 1 expression in ameloblastoma and odontogenic keratocyst-A comparative immunohistochemical study [J]. J Oral Maxillofac Pathol, 2022, 26(2):185-191.
[15] You Z, Du J, Xu LL, et al. Expressions of GLUT-1, PK-M2 and HIF-1α and mutation status of BRAF in odontogenic keratocysts [J]. Chin J Dent Res, 2022, 25(4):285-291.
[16] Zheng F, Chen J, Zhang X, et al. The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis [J]. Nat Commun, 2021, 12(1):1341.
[17] Sadri D, Farhadi S, Nourmohamadi P. Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression [J]. Dent Res J (Isfahan), 2019, 16(5):327-332.
[18] Alquraishi M, Puckett DL, Alani DS, et al. Pyruvate kinase M2: A simple molecule with complex functions [J]. Free Radic Biol Med, 2019, 143:176-192.
[19] Tao T, Su Q, Xu S, et al. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis [J]. J Cell Physiol, 2019, 234(3):3088-3104.
[20] Ortiz-García JZ, Munguía-Robledo S, Estrada-Orozco JJ, et al. Expression level and proteolytic activity of MMP-2 and MMP-9 in dental follicles, dentigerous cysts, odontogenic keratocysts and unicystic ameloblastomas [J]. J Oral Biol Craniofac Res, 2022, 12(3):339-342.
[21] Zhu T, Wang R, Jiang H, et al. Fibroblast programmed cell death ligand 1 promotes osteoclastogenesis in odontogenic keratocysts [J]. Am J Pathol, 2023, 193(3):286-295.
[22] Phattarataratip E, Panitkul T, Khodkaew W, et al. Expression of SOX2 and OCT4 in odontogenic cysts and tumors [J]. Head Face Med, 2021, 17(1):29.
[23] Zhu Q, Hong B, Zhang L, et al. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway [J]. J Cancer Res Ther, 2018, 14(Supplement):S616-S621.
[24] Júnior JF, de França GM, da Silva Barros CC, et al. Biomarkers involved in the proliferation of the odontogenic keratocyst, glandular odontogenic cyst and botryoid odontogenic cyst [J]. Oral Maxillofac Surg, 2022, 26(4):655-662.
[25] Doll C, Dauter K, Jöhrens K, et al. Clinical characteristics and immunohistochemical analysis of p53, Ki-67 and cyclin D1 in 80 odontogenic keratocysts [J]. J Stomatol Oral Maxillofac Surg, 2018, 119(5):359-364.
[26] Yang X, Chen W, Zhao X, et al. Pyruvate kinase M2 modulates the glycolysis of chondrocyte and extracellular matrix in osteoarthritis [J]. DNA Cell Biol, 2018, 37(3):271-277.
[27] Gupta A, Ajith A, Singh S, et al. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect [J]. Cell Death Dis, 2018, 9(8):825.
[28] Alquraishi M, Puckett DL, Alani DS, et al. Pyruvate kinase M2: A simple molecule with complex functions [J]. Free Radic Biol Med, 2019, 143:176-192.
[29] Gu J, Li X, Zhao L, et al. The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts [J]. Cell Death Dis, 2021, 12(4):291.
[30] Van Niekerk G, Engelbrecht AM. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target [J]. Cell Oncol (Dordr), 2018, 41(4):343-351.